Aberrant DNA methylation is a dominant mechanism in MDS progression to AML

Myelodysplastic syndromes (MDSs) are clonal hematologic disorders that frequently represent an intermediate disease stage before progression to acute myeloid leukemia (AML). As such, study of MDS/AML can provide insight into the mechanisms of neoplastic evolution. In 184 patients with MDS and AML, D...

Полное описание

Сохранить в:
Библиографические подробности
Главные авторы: Jiang, Ying, Dunbar, Andrew, Gondek, Lukasz P., Mohan, Sanjay, Rataul, Manjot, O'Keefe, Christine, Sekeres, Mikkael, Saunthararajah, Yogen, Maciejewski, Jaroslaw P.
Формат: Artigo
Язык:Inglês
Опубликовано: American Society of Hematology 2009
Предметы:
Myeloid Neoplasia
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC2637194/
https://ncbi.nlm.nih.gov/pubmed/18832655
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2008-06-163246
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы